Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Operating Margin (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Operating Margin for 17 consecutive years, with 1.69% as the latest value for Q1 2026.

  • Quarterly Operating Margin fell 216.0% to 1.69% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 4.05% through Jan 2026, down 372.0% year-over-year, with the annual reading at 4.05% for FY2026, 372.0% down from the prior year.
  • Operating Margin for Q1 2026 was 1.69% at Usana Health Sciences, up from 0.57% in the prior quarter.
  • The five-year high for Operating Margin was 12.76% in Q1 2022, with the low at 0.57% in Q3 2025.
  • Average Operating Margin over 5 years is 8.37%, with a median of 9.7% recorded in 2022.
  • The sharpest move saw Operating Margin surged 106bps in 2023, then crashed -722bps in 2025.
  • Over 5 years, Operating Margin stood at 9.89% in 2022, then increased by 11bps to 10.95% in 2023, then tumbled by -65bps to 3.84% in 2024, then tumbled by -85bps to 0.57% in 2025, then soared by 195bps to 1.69% in 2026.
  • According to Business Quant data, Operating Margin over the past three periods came in at 1.69%, 0.57%, and 7.09% for Q1 2026, Q3 2025, and Q2 2025 respectively.